By reducing systemic inflammation, the KD may help alleviate pelvic pain and other inflammatory symptoms associated with the disease [11,12,13]
Compounded medications are not FDA-approved and are intended for individual use only
GLP-1 medications, such as semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound), were originally developed for type 2 diabetes and later approved for chronic weight management at full therapeutic doses
That's where NAD injections offer a considerable advantage: quick, consistent, and easy to schedule
GLP-1 receptor agonist medications like semaglutide are temperature-sensitive compounds that require careful storage to maintain their therapeutic strength
This medication is also titrated, and the starting dose is typically 0.5 mg